Sotera Health CoSHCEarnings & Financial Report
Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.
Revenue
$290.2M
Gross Profit
$164.4M
Operating Profit
$87.1M
Net Profit
$12.3M
Gross Margin
56.6%
Operating Margin
30.0%
Net Margin
4.2%
YoY Growth
-6.5%
EPS
$0.05
Financial Flow
Sotera Health Co Q4 2024 Financial Summary
Sotera Health Co reported revenue of $290.2M (down 6.5% YoY) for Q4 2024, with a net profit of $12.3M (down 68.1% YoY) (4.2% margin). Cost of goods sold was $125.8M, operating expenses totaled $77.2M.
Key Financial Metrics
| Total Revenue | $290.2M |
|---|---|
| Net Profit | $12.3M |
| Gross Margin | 56.6% |
| Operating Margin | 30.0% |
| Report Period | Q4 2024 |
Revenue Breakdown
Sotera Health Co Q4 2024 revenue of $290.2M breaks down across 3 segments, led by Transferred At Point In Time at $179.4M (61.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Transferred At Point In Time | $179.4M | 61.8% |
| Nordion | $56.8M | 19.6% |
| Nelson Labs | $54.0M | 18.6% |
Sotera Health Co Revenue by Segment — Quarterly Trend
Sotera Health Co revenue by segment across the last 4 reported quarters, showing how each business line (such as Transferred At Point In Time and Nordion) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Transferred At Point In Time | $198.4M | $192.8M | $194.8M | $169.7M |
| Nordion | $49.8M | $62.8M | $42.4M | $32.6M |
| Nelson Labs | $55.2M | $55.7M | $57.1M | — |
Sotera Health Co Annual Revenue by Year
Sotera Health Co annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.2B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.2B |
| 2024 | $1.1B |
| 2023 | $1.0B |
| 2022 | $1.0B |
Sotera Health Co Quarterly Revenue & Net Profit History
Sotera Health Co results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $303.4M | +4.6% | $34.8M | 11.5% |
| Q3 2025 | $311.3M | +9.1% | $48.4M | 15.5% |
| Q2 2025 | $294.3M | +6.4% | $8.0M | 2.7% |
| Q1 2025 | $254.5M | +2.6% | $-13.3M | -5.2% |
| Q4 2024 | $290.2M | -6.5% | $12.3M | 4.2% |
| Q3 2024 | $285.5M | +8.5% | $17.0M | 6.0% |
| Q2 2024 | $276.6M | +8.3% | $8.8M | 3.2% |
| Q1 2024 | $248.2M | +12.5% | $6.3M | 2.5% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $248.2M | $276.6M | $285.5M | $290.2M | $254.5M | $294.3M | $311.3M | $303.4M |
| YoY Growth | 12.5% | 8.3% | 8.5% | -6.5% | 2.6% | 6.4% | 9.1% | 4.6% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $3.06B | $3.06B | $3.15B | $3.07B | $3.10B | $3.22B | $3.19B | $3.26B |
| Liabilities | $2.63B | $2.64B | $2.68B | $2.67B | $2.68B | $2.71B | $2.64B | $2.66B |
| Equity | $429.4M | $422.8M | $470.2M | $404.9M | $414.1M | $511.3M | $550.5M | $606.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $9.7M | $61.3M | $97.5M | $55.7M | $55.5M | $57.4M | $71.2M | $103.1M |